Bepirovirsen in Combination with Peg-IFN and Other Molecules - Stuart Kendrick, MD, PhD, MRCP

International Workshop on HBV Cure 2023

Second Generation CAMs Leading to HBsAg Decline - Matthew McClure, MD

International Workshop on HBV Cure 2023

Does siRNA Restore Host Control and Could it Lead to Sustained HBsAg Suppression? - Michael J. Sofia, Ph.D

International Workshop on HBV Cure 2023

Discrimination of Integrated vs. cccDNA Derived HBsAg - Chloe Thio, MD

International Workshop on HBV Cure 2023

Anti-HBs Monoclonal Antibodes in Nuc-naïve and Combo Therapies - Carey Hwang, MD, PhD

International Workshop on HBV Cure 2023

Value of Adding Recombinant Antigens to Viral Vector Vaccines - Ventzi Vassilev, PhD

International Workshop on HBV Cure 2023

Efficacy and Safety of Targeting PD-L1 with Monoclonal Antibodies - Jinzi J. Wu, Ph.D.

International Workshop on HBV Cure 2023

Immunological Profiles Induced by New Therapeutic Vaccines - Eleanor Barnes, PhD, FRCP, F. Med. Sci.

International Workshop on HBV Cure 2023

Balance of Response and Adverse Events in Immunotherapy for CHB - Jordan Feld, MD, MPH

International Workshop on HBV Cure 2023

Next Generation CAMs, New Life for Small Molecules? - Mark Sulkowski, MD

International Workshop on HBV Cure 2023

Latest Updates on Novel Biomarkers in HBV Cure - Man-Fung Yuen, MBBS, MD, PhD, DSc

International Workshop on HBV Cure 2023

Are We Only Able to Suppress HDV or is Cure in Reach? - Pietro Lampertico, MD, PhD

International Workshop on HBV Cure 2023

Expanding CHB Treatment Criteria with Nucs as Prelude of Novel Curative Therapies? - Harry Janssen, MD, PhD

International Workshop on HBV Cure 2023

Durability of Response After DAA Therapies - Fabien Zoulim, MD, PhD

International Workshop on HBV Cure 2023

DC Community Conversation on Aging and HIV

International Workshop on HIV & Aging 2023

Community Forum: Challenges and Proposed Solutions

International Workshop on HIV & Aging 2023

Asymptomatic Neurocognitive Impairment in People Living With HIV - Impact of (Not) Knowing

International Workshop on HIV & Aging 2023

Age-related Changes in the PK of Long-Acting Drugs in the Elderly - Charles Flexner, MD

International Workshop on HIV & Aging 2023

#19 - Inverse Balance in Plasma Levels of the Endocannabinoids N-arachidonoylethanolamine and 2-arachidonoylglycerol and their Congeners in People with HIV with Subclinical Coronary Artery Disease (..) - Cecilia Costiniuk

International Workshop on HIV & Aging 2023

#18 - Plasma Proteomic Signatures Capture Unique Cardiovascular Risk Phenotypes Among Persons Living With and Without HIV in the United States - Tess Peterson

International Workshop on HIV & Aging 2023

#17 - Cardiometabolic Disease Among Frailty Phenotype Clusters in Adults Aging with HIV - Ray Jones

International Workshop on HIV & Aging 2023

Multifactorial Risk Factors for Cognitive Impairment - Scott Letendre, MD

International Workshop on HIV & Aging 2023

Focus on Global Mentorship - Charles Flexner, MD

International Workshop on HIV & Aging 2023

#16 - Emotional, Not Social, Loneliness Is Related to Objective Cognitive Function in Older People With HIV - Moka Yoo-Jeong

International Workshop on HIV & Aging 2023